Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Wayne Chen

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Circulation Research|July 17, 2013
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in miceYunlong Bai, Peter P Jones, Jiqing Guo, et al.
Current Protocols|December 27, 2021
Using hiPSC-CMs to Examine Mechanisms of Catecholaminergic Polymorphic Ventricular TachycardiaAlia Arslanova, Sanam Shafaattalab, Kevin Ye, et al.
The Biochemical Journal|July 26, 2023
RyR2 C-terminal truncating variants identified in patients with arrhythmic phenotypes exert a dominant negative effect through formation of wildtype-truncation heteromersShanshan Tian, Xiaowei Zhong, Hui Wang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 30, 2018
Non-β-Blocking Carvedilol Analog, VK-II-86, Prevents Ouabain-Induced CardiotoxicityLuis A Gonano, Marisa Sepúlveda, Malena Morell, et al.
Circulation Research|September 10, 2011
Phosphodiesterase 4D regulates baseline sarcoplasmic reticulum Ca2+ release and cardiac contractility, independently of L-type Ca2+ currentSanja Beca, Peter B Helli, Jeremy A Simpson, et al.
Circulation. Genomic and Precision Medicine|December 24, 2021
Provocation Testing and Therapeutic Response in a Newly Described Channelopathy: RyR2 Calcium Release Deficiency SyndromeJulian O M Ormerod, Elizabeth Ormondroyd, Yanhui Li, et al.
Nature Communications|February 10, 2022
Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearancePaul F Lebeau, Jae Hyun Byun, Khrystyna Platko, et al.
Circulation. Arrhythmia and Electrophysiology|September 21, 2021
Human RyR2 (Ryanodine Receptor 2) Loss-of-Function Mutations: Clinical Phenotypes and In Vitro CharacterizationYanhui Li, Jinhong Wei, Wenting Guo, et al.
Communications Biology|March 2, 2022
Subcellular localization of hippocampal ryanodine receptor 2 and its role in neuronal excitability and memoryFlorian Hiess, Jinjing Yao, Zhenpeng Song, et al.
Cell Reports|September 23, 2020
Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid AccumulationJinjing Yao, Bo Sun, Adam Institoris, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Circulation Research|July 17, 2013
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in miceYunlong Bai, Peter P Jones, Jiqing Guo, et al.
Current Protocols|December 27, 2021
Using hiPSC-CMs to Examine Mechanisms of Catecholaminergic Polymorphic Ventricular TachycardiaAlia Arslanova, Sanam Shafaattalab, Kevin Ye, et al.
The Biochemical Journal|July 26, 2023
RyR2 C-terminal truncating variants identified in patients with arrhythmic phenotypes exert a dominant negative effect through formation of wildtype-truncation heteromersShanshan Tian, Xiaowei Zhong, Hui Wang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 30, 2018
Non-β-Blocking Carvedilol Analog, VK-II-86, Prevents Ouabain-Induced CardiotoxicityLuis A Gonano, Marisa Sepúlveda, Malena Morell, et al.
Circulation Research|September 10, 2011
Phosphodiesterase 4D regulates baseline sarcoplasmic reticulum Ca2+ release and cardiac contractility, independently of L-type Ca2+ currentSanja Beca, Peter B Helli, Jeremy A Simpson, et al.
Circulation. Genomic and Precision Medicine|December 24, 2021
Provocation Testing and Therapeutic Response in a Newly Described Channelopathy: RyR2 Calcium Release Deficiency SyndromeJulian O M Ormerod, Elizabeth Ormondroyd, Yanhui Li, et al.
Nature Communications|February 10, 2022
Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearancePaul F Lebeau, Jae Hyun Byun, Khrystyna Platko, et al.
Circulation. Arrhythmia and Electrophysiology|September 21, 2021
Human RyR2 (Ryanodine Receptor 2) Loss-of-Function Mutations: Clinical Phenotypes and In Vitro CharacterizationYanhui Li, Jinhong Wei, Wenting Guo, et al.
Communications Biology|March 2, 2022
Subcellular localization of hippocampal ryanodine receptor 2 and its role in neuronal excitability and memoryFlorian Hiess, Jinjing Yao, Zhenpeng Song, et al.
Cell Reports|September 23, 2020
Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid AccumulationJinjing Yao, Bo Sun, Adam Institoris, et al.
Pageof 15